MedTrace Logo

Sample Collection From Melanoma Patients

NCT00507325 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2022-09-02

No results posted yet for this study

Summary

The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.

Conditions

Interventions

PROCEDURE

Blood Sample

Blood samples will be collected.

PROCEDURE

Tumor Sample

Tumor samples will be collected using a small needle, a punch knife, or a small surgery.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Michael Davies, MD · M.D. Anderson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-13
Primary Completion
2022-08-01
Completion
2022-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507325 on ClinicalTrials.gov